New hope for Tough-to-Treat cancers: experimental drug enters human trials
Disease control
Not yet recruiting
This study is testing an experimental drug called atamparib in adults with advanced lung cancer or other solid tumors that have spread. It aims to find the safest dose and see if the drug can shrink tumors in people who have already tried standard treatments and have a specific g…
Phase: PHASE1, PHASE2 • Sponsor: Nerviano Medical Sciences (Shanghai) Ltd. • Aim: Disease control
Last updated Apr 01, 2026 21:41 UTC